Accolade Inc
NASDAQ:ACCD
Intrinsic Value
Accolade, Inc. engages in the provision of personalized health and benefits solutions. [ Read More ]
The intrinsic value of one ACCD stock under the Base Case scenario is 16.47 USD. Compared to the current market price of 9.19 USD, Accolade Inc is Undervalued by 44%.
Valuation Backtest
Accolade Inc
Run backtest to discover the historical profit from buying and selling ACCD stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Accolade Inc
Current Assets | 272.1m |
Cash & Short-Term Investments | 230m |
Receivables | 25.6m |
Other Current Assets | 16.5m |
Non-Current Assets | 513.4m |
PP&E | 48.1m |
Intangibles | 452.7m |
Other Non-Current Assets | 12.6m |
Current Liabilities | 115.7m |
Accounts Payable | 12.7m |
Accrued Liabilities | 41.1m |
Other Current Liabilities | 61.9m |
Non-Current Liabilities | 235.1m |
Long-Term Debt | 208.2m |
Other Non-Current Liabilities | 26.9m |
Earnings Waterfall
Accolade Inc
Revenue
|
388.5m
USD
|
Cost of Revenue
|
-214.4m
USD
|
Gross Profit
|
174.1m
USD
|
Operating Expenses
|
-310m
USD
|
Operating Income
|
-135.9m
USD
|
Other Expenses
|
13.1m
USD
|
Net Income
|
-122.7m
USD
|
Free Cash Flow Analysis
Accolade Inc
ACCD Profitability Score
Profitability Due Diligence
Accolade Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Accolade Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
ACCD Solvency Score
Solvency Due Diligence
Accolade Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Accolade Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACCD Price Targets Summary
Accolade Inc
According to Wall Street analysts, the average 1-year price target for ACCD is 15.37 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.
Ownership
ACCD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ACCD Price
Accolade Inc
Average Annual Return | -22.65% |
Standard Deviation of Annual Returns | 57.23% |
Max Drawdown | -91% |
Market Capitalization | 707.3m USD |
Shares Outstanding | 77 407 600 |
Percentage of Shares Shorted | 4.25% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
Contact
IPO
Employees
Officers
The intrinsic value of one ACCD stock under the Base Case scenario is 16.47 USD.
Compared to the current market price of 9.19 USD, Accolade Inc is Undervalued by 44%.